Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17632 ↗At a glance
Kohortenstudie in Alimentary Pharmacology & Therapeutics, 2023. Written by Colin J Crooks and 6 co-authors. Institution: Gastrointestinal and Liver Theme, Nottingham Biomedical Research Centre (BRC), Queen's Medical Centre, School of Medicine, National Institute for Hea…. Major MEDLINE topics: Colorectal Neoplasms, Anemia. Cited 24 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
A faecal immunochemical tests (FIT) cut‐off of ≥10 μg Hb/g faeces is now recommended in the UK as a gateway to urgent (suspected cancer) investigation for colorectal cancer (CRC), based on an expected CRC risk threshold of 3%.
Aims
To quantify the risk of CRC at FIT cut‐offs by age, haemoglobin and platelet strata.
Methods
A cohort study of a symptomatic CRC pathway based on primary care FIT tests in Nottingham, UK (November 2017–2021) with 1‐year follow‐up. Heat maps showed the cumulative 1‐year CRC risk using Kaplan–Meier estimates.
Results
In total, 514 (1.5%) CRCs were diagnosed following 33,694 index FIT requests. Individuals with a FIT ≥ 10 μg Hb/g faeces had a >3% risk of CRC, except patients under the age of 40 years (CRC risk 1.45% [95% CI: 0.03%–2.86%]). Non‐anaemic patients with a FIT < 100 μg Hb/g faeces had a CRC risk of
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Gastrointestinal and Liver Theme, Nottingham Biomedical Research Centre (BRC), Queen's Medical Centre, School of Medicine, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust, Univer…
- Nottingham Colorectal Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Nottingham Bowel Cancer Screening Hub, School of Medicine, University of Nottingham, Nottingham, UK.
- Nottingham City Clinical Commissioning Group Nottingham UK, School of Medicine, University of Nottingham, Nottingham, UK.
- Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
ORCID profiles: Colin J Crooks, Ayan Banerjea, Joe West, David J Humes
Cite
APA
Crooks, C. J., Banerjea, A., Jones, J., Chapman, C., Oliver, S., West, J., & Humes, D. J. (2023). Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17632
Vancouver
Crooks CJ, Banerjea A, Jones J, Chapman C, Oliver S, West J, et al. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17632
BibTeX
@article{Crooks2023,
author = {Crooks, Colin J and Banerjea, Ayan and Jones, James and Chapman, Caroline and Oliver, Simon and West, Joe and Humes, David J},
title = {Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17632}
}
EUVIMED